SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Collegium Pharmaceutical, Inc. Announces Initiation of Enrollment in Phase 3 Efficacy Study of Oxycodone DETERx® in Subjects With Moderate to Severe Chronic Lower Back Pain